Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2002 2
2003 1
2004 2
2005 4
2006 3
2007 4
2008 8
2009 7
2010 8
2011 5
2012 6
2013 14
2014 14
2015 28
2016 23
2017 21
2018 31
2019 26
2020 40
2021 34
2022 36
2023 22
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased risk for lymphoma"
Page 1
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Renehan AG, et al. Lancet. 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X. Lancet. 2008. PMID: 18280327 Review.
BACKGROUND: Excess bodyweight, expressed as increased body-mass index (BMI), is associated with the risk of some common adult cancers. ...INTERPRETATION: Increased BMI is associated with increased risk of common and less common malignancies. ...
BACKGROUND: Excess bodyweight, expressed as increased body-mass index (BMI), is associated with the risk of some common adult …
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis.
Vaengebjerg S, Skov L, Egeberg A, Loft ND. Vaengebjerg S, et al. JAMA Dermatol. 2020 Apr 1;156(4):421-429. doi: 10.1001/jamadermatol.2020.0024. JAMA Dermatol. 2020. PMID: 32074260 Free PMC article.
No increased risk of cancer for patients with psoriasis treated with biologic agents was found (RR, 0.97; 95% CI, 0.85-1.10). Psoriatic arthritis was not associated with increased risk of cancer overall (RR, 1.02; 95% CI, 0.97-1.08). CONCLUSIONS AND RE …
No increased risk of cancer for patients with psoriasis treated with biologic agents was found (RR, 0.97; 95% CI, 0.85-1.10). …
Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review.
Yadav V, Ganesan P, Veeramani R, Kumar V D. Yadav V, et al. Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e57-e65. doi: 10.1016/j.clml.2020.08.011. Epub 2020 Aug 18. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33485429 Review.
Generally, Ph-like ALL is associated with adverse clinical features and an increased risk of treatment failure with conventional approaches. Genetic alterations such as aberrant expression, point mutations, or fusion translocations lead to activation of cytokine rec …
Generally, Ph-like ALL is associated with adverse clinical features and an increased risk of treatment failure with convention …
Primary Sjogren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, Zeng X. Zhong H, et al. Autoimmun Rev. 2022 May;21(5):103084. doi: 10.1016/j.autrev.2022.103084. Epub 2022 Mar 24. Autoimmun Rev. 2022. PMID: 35341972 Review.
OBJECTIVE: Patients with primary Sjogren's syndrome(pSS) have increased risk of non-Hodgkin lymphoma (NHL). However, whether pSS patients have increased risk of other malignancies is unclear. ...CONCLUSION: This meta-analysis showed that pSS pat …
OBJECTIVE: Patients with primary Sjogren's syndrome(pSS) have increased risk of non-Hodgkin lymphoma (NHL). However, wh …
Topical tacrolimus for atopic dermatitis.
Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM. Cury Martins J, et al. Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2. Cochrane Database Syst Rev. 2015. PMID: 26132597 Free PMC article. Review.
Compared with the lower concentration of 0.03%, the tacrolimus 0.1% formulation reduced the risk of not having an improvement by 18% as evaluated by the physician's assessment (RR 0.82, 95% CI 0.72 to 0.92, 6 studies, n = 1640, high-quality evidence). ...Both tacrolimus fo …
Compared with the lower concentration of 0.03%, the tacrolimus 0.1% formulation reduced the risk of not having an improvement by 18% …
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases: A Systematic Review and Meta-Analysis.
Ingrassia JP, Maqsood MH, Gelfand JM, Weber BN, Bangalore S, Lo Sicco KI, Garshick MS. Ingrassia JP, et al. JAMA Dermatol. 2024 Jan 1;160(1):28-36. doi: 10.1001/jamadermatol.2023.4090. JAMA Dermatol. 2024. PMID: 37910098
IMPORTANCE: Janus kinase (JAK) inhibitors are an effective treatment option for patients with certain skin-related conditions, such as atopic dermatitis, alopecia areata, and vitiligo, but there is a current US Food and Drug Administration (FDA) boxed warning label for oral and t …
IMPORTANCE: Janus kinase (JAK) inhibitors are an effective treatment option for patients with certain skin-related conditions, such as atopi …
Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: A meta-analysis and supporting evidence.
Zhang L, Rana I, Shaffer RM, Taioli E, Sheppard L. Zhang L, et al. Mutat Res Rev Mutat Res. 2019 Jul-Sep;781:186-206. doi: 10.1016/j.mrrev.2019.02.001. Epub 2019 Feb 10. Mutat Res Rev Mutat Res. 2019. PMID: 31342895 Free PMC article.
We investigated whether there was an association between high cumulative exposures to GBHs and increased risk of non-Hodgkin lymphoma (NHL) in humans. We conducted a new meta-analysis that includes the most recent update of the Agricultural Health Study (AHS) …
We investigated whether there was an association between high cumulative exposures to GBHs and increased risk of non-Hodgkin …
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
Cameron LB, Hitchen N, Chandran E, Morris T, Manser R, Solomon BJ, Jordan V. Cameron LB, et al. Cochrane Database Syst Rev. 2022 Jan 7;1(1):CD013453. doi: 10.1002/14651858.CD013453.pub2. Cochrane Database Syst Rev. 2022. PMID: 34994987 Free PMC article. Review.
DATA COLLECTION AND ANALYSIS: Two review authors independently assessed studies for eligibility, extracted study characteristics and outcome data, and assessed risk of bias using the Cochrane risk of bias tool for each included study. ...We assessed the evidence for …
DATA COLLECTION AND ANALYSIS: Two review authors independently assessed studies for eligibility, extracted study characteristics and outcome …
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Ernst M, Oeser A, Besiroglu B, Caro-Valenzuela J, Abd El Aziz M, Monsef I, Borchmann P, Estcourt LJ, Skoetz N, Goldkuhle M. Ernst M, et al. Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2. Cochrane Database Syst Rev. 2021. PMID: 34515338 Free PMC article. Review.
In three studies (253 participants), 56% to 68% of participants experienced serious adverse events, while in one study (28 participants), no serious adverse events occurred. CAR T-cell therapy may increase the risk of adverse events and serious adverse events but th …
In three studies (253 participants), 56% to 68% of participants experienced serious adverse events, while in one study (28 participants), no …
Adverse effects of biologics: a network meta-analysis and Cochrane overview.
Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, Filippini G, Skoetz N, Francis D, Lopes LC, Guyatt GH, Schmitt J, La Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Lunn MP, Tugwell P, Buchbinder R. Singh JA, et al. Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD008794. doi: 10.1002/14651858.CD008794.pub2. Cochrane Database Syst Rev. 2011. PMID: 21328309 Free PMC article. Review.
Since serious risks such as tuberculosis (TB) reactivation, serious infections, and lymphomas may be common to the biologics but occur in small numbers across the various indications, we planned to combine the results from biologics used in many conditions to obtain the mu …
Since serious risks such as tuberculosis (TB) reactivation, serious infections, and lymphomas may be common to the biologics but occu …
294 results